Google
OGEN — ORAGENICS INC (Healthcare >> Biotechnology)
OGEN FAQ
What is OGEN's ROE?
ORAGENICS INC reports a Return on Equity (ROE) of -158.96%.
What is OGEN's dividend yield?
ORAGENICS INC offers a dividend yield of 0.00%.
What is OGEN's Deepscope Quality Score?
Deepscope rates OGEN's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy OGEN?
Deepscope's AI Timing Score for OGEN is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does OGEN belong to?
ORAGENICS INC is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 0.59
Price
-0.01
(-1.16%)
Day Change
|
|
|---|
OGEN, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.59 |
| PBV / Sector |
0.44 / 4.63
GREAT
|
| Earning Per Share | -2.15 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.04 M
GREAT
|
| Average 1W Daily Value |
0.05 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
43% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:51 |
| Symbol | OGEN |
| Name | ORAGENICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 4.51 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2.71 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 9015 Town Center Parkway, Lakewood Ranch, FL, United States, 34202
Phone: 813 286 7900
Website: https://www.oragenics.com
Sector: Healthcare >> Biotechnology
Description: Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
